Key result
Telemonitoring using a combination of apps, patient-reported outcome measures, and non-invasive sensors was evaluated across 8 studies for patients with cardiovascular diseases.
Why the study?
New sensor technologies provide opportunities to collect real-world data, prompting an investigation into the status quo of studies monitoring patients with cardiovascular risks or diseases using smartphone apps and consumer health devices.
Systematic Review (n=8)
A combination of apps, patient-reported outcome measures, and non-invasive sensors can meaningfully contribute to out-of-hospital monitoring concepts for cardiovascular patients.
Supports combined telemonitoring evaluation in CVD; extends evidence base from 8 studies but leaves optimal use open.
BACKGROUND: New sensor technologies in wearables and other consumer health devices open up promising opportunities to collect real-world data. As cardiovascular diseases remain the number one reason for disease and mortality worldwide, cardiology offers potent monitoring use cases with patients in their out-of-hospital daily routines. Therefore, the aim of this systematic review is to investigate the status quo of studies monitoring patients with cardiovascular risks and patients suffering from cardiovascular diseases in a telemedical setting using not only a smartphone-based app, but also consumer health devices such as wearables and other sensor-based devices. METHODS: A literature search was conducted across five databases, and the results were examined according to the study protocols, technical approaches, and qualitative and quantitative parameters measured. RESULTS: Out of 166 articles, 8 studies were included in this systematic review; these cover interventional and observational monitoring approaches in the area of cardiovascular diseases, heart failure, and atrial fibrillation using various app, wearable, and health device combinations. CONCLUSIONS: Depending on the researcher's motivation, a fusion of apps, patient-reported outcome measures, and non-invasive sensors can be orchestrated in a meaningful way, adding major contributions to monitoring concepts for both individual patients and larger cohorts.
No takes yet. Share an insight, caveat, or question.
Kinast et al. (2021) conducted a systematic review in Cardiovascular diseases, heart failure, and atrial fibrillation (n=8). Telemonitoring using apps and consumer health devices was evaluated on Status quo of telemonitoring studies. Telemonitoring using a combination of apps, patient-reported outcome measures, and non-invasive sensors was evaluated across 8 studies for patients with cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: